DK0752847T3 - Ophthalmisk sammensætning med nedsat viskositet - Google Patents

Ophthalmisk sammensætning med nedsat viskositet

Info

Publication number
DK0752847T3
DK0752847T3 DK95914362T DK95914362T DK0752847T3 DK 0752847 T3 DK0752847 T3 DK 0752847T3 DK 95914362 T DK95914362 T DK 95914362T DK 95914362 T DK95914362 T DK 95914362T DK 0752847 T3 DK0752847 T3 DK 0752847T3
Authority
DK
Denmark
Prior art keywords
amount
pct
weight
viscosity
composition
Prior art date
Application number
DK95914362T
Other languages
Danish (da)
English (en)
Inventor
Kari Lehmussaari
Timo Reunamaeki
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0752847T3 publication Critical patent/DK0752847T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95914362T 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet DK0752847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (fr) 1994-03-31 1995-03-29 Composition ophtalmique a viscosite reduite

Publications (1)

Publication Number Publication Date
DK0752847T3 true DK0752847T3 (da) 2001-10-22

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914362T DK0752847T3 (da) 1994-03-31 1995-03-29 Ophthalmisk sammensætning med nedsat viskositet

Country Status (27)

Country Link
US (1) US5710182A (fr)
EP (1) EP0752847B1 (fr)
JP (1) JPH10503470A (fr)
KR (1) KR100365914B1 (fr)
CN (1) CN1112918C (fr)
AT (1) ATE202921T1 (fr)
AU (1) AU694497B2 (fr)
BG (1) BG63145B1 (fr)
BR (1) BR9507438A (fr)
CA (1) CA2186734A1 (fr)
CZ (1) CZ290987B6 (fr)
DE (2) DE752847T1 (fr)
DK (1) DK0752847T3 (fr)
EE (1) EE03661B1 (fr)
ES (1) ES2161874T3 (fr)
GR (1) GR3036763T3 (fr)
HK (1) HK1013953A1 (fr)
HU (1) HU223071B1 (fr)
MX (1) MX9603918A (fr)
NO (1) NO314434B1 (fr)
PL (1) PL179433B1 (fr)
PT (1) PT752847E (fr)
RO (1) RO115409B1 (fr)
RU (1) RU2139016C1 (fr)
SE (1) SE9401108D0 (fr)
SK (1) SK280492B6 (fr)
WO (1) WO1995026711A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000064528A1 (fr) 1999-04-28 2000-11-02 Situs Corporation Systeme d'apport de medicaments
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
AU2003213210A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
EP1484054B1 (fr) * 2002-02-22 2012-08-29 Santen Pharmaceutical Co., Ltd. Systeme d'administration de medicament destine a administrer de facon subconjonctivale des grains fins
CN100453066C (zh) * 2002-12-04 2009-01-21 参天制药株式会社 利用结膜下储存库的药物释放系统
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839847C (fr) * 2003-06-13 2016-03-15 Masood A. Chowhan Compositions ophtalmologiques contenant une association synergique de deux polymeres
CA2536185C (fr) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Systeme d'administration de produit pharmaceutique pour administrer des fins grains sous la capsule de tenon
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
EP2334686B1 (fr) 2008-08-28 2019-02-27 President and Fellows of Harvard College Analogues de cortistatine et leurs synthèses
EP2383286A1 (fr) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions pour le traitement des maladies rétiniennes dégénératives
JP2012180346A (ja) * 2011-02-10 2012-09-20 Santen Pharmaceut Co Ltd 親水性薬物の薬物移行性を改善した水性組成物
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
PE20161405A1 (es) 2013-12-24 2017-01-18 Harvard College Analogos de cortistatina y sintesis y usos de los mismos
EP3294298A4 (fr) 2015-05-08 2018-10-17 President and Fellows of Harvard College Analogues de la cortistatine, synthèses, et utilisations de ces derniers
EP3316889A4 (fr) 2015-07-01 2018-11-14 President and Fellows of Harvard College Analogues de la cortistatine, et synthèses et leurs utilisations
EP3340982B1 (fr) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Composés pour le traitement de troubles immunitaires et inflammatoires
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017143220A1 (fr) 2016-02-17 2017-08-24 Children's Medical Center Corporation Ffa1 (gpr40) utilisé comme cible thérapeutique pour des maladies ou des troubles neuronaux liés à l'angiogenèse
WO2018005552A1 (fr) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Composés de quinazoline et d'indole destinés au traitement de troubles médicaux
WO2018033854A1 (fr) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Composition ophtalmique et procédé de traitement de l'hypertension oculaire et du glaucome
CN116726006A (zh) 2016-08-19 2023-09-12 阿拉西斯医药公司 眼科药物组合物及其相关用途
RS62817B1 (sr) * 2017-05-11 2022-02-28 Vyluma Inc Farmaceutske kompozicije atropina
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
JP2021535112A (ja) 2018-08-20 2021-12-16 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
EP3866773A4 (fr) 2018-10-16 2022-10-26 Georgia State University Research Foundation, Inc. Promédicaments de monoxyde de carbone pour le traitement de troubles médicaux
CA3205883A1 (fr) * 2021-02-04 2022-08-11 Gregory I. Ostrow Compositions ophtalmiques pour la presbytie
EP4088713A1 (fr) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Composition pharmaceutique ophtalmique comprenant de l'atropine
EP4088714A1 (fr) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Composition pharmaceutique ophtalmique comprenant de l'atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

Also Published As

Publication number Publication date
EE9600120A (et) 1997-04-15
DE752847T1 (de) 1997-09-04
NO964070L (no) 1996-11-28
SK123996A3 (en) 1997-06-04
AU2138995A (en) 1995-10-23
SK280492B6 (sk) 2000-03-13
EP0752847A1 (fr) 1997-01-15
HK1013953A1 (en) 1999-09-17
HU223071B1 (hu) 2004-03-01
JPH10503470A (ja) 1998-03-31
KR100365914B1 (ko) 2003-04-16
DE69521686T2 (de) 2002-04-25
CA2186734A1 (fr) 1995-10-12
ES2161874T3 (es) 2001-12-16
MX9603918A (es) 1997-04-30
PT752847E (pt) 2001-12-28
KR970702024A (ko) 1997-05-13
GR3036763T3 (en) 2001-12-31
EE03661B1 (et) 2002-04-15
US5710182A (en) 1998-01-20
BG63145B1 (bg) 2001-05-31
SE9401108D0 (sv) 1994-03-31
BR9507438A (pt) 1997-09-16
EP0752847B1 (fr) 2001-07-11
PL316584A1 (en) 1997-01-20
RO115409B1 (ro) 2000-02-28
BG100915A (en) 1997-07-31
AU694497B2 (en) 1998-07-23
CZ286596A3 (en) 1997-04-16
WO1995026711A1 (fr) 1995-10-12
PL179433B1 (pl) 2000-09-29
HU9602691D0 (en) 1996-11-28
RU2139016C1 (ru) 1999-10-10
CN1144477A (zh) 1997-03-05
NO964070D0 (no) 1996-09-27
DE69521686D1 (de) 2001-08-16
NO314434B1 (no) 2003-03-24
CN1112918C (zh) 2003-07-02
HUT75666A (en) 1997-05-28
CZ290987B6 (cs) 2002-11-13
ATE202921T1 (de) 2001-07-15

Similar Documents

Publication Publication Date Title
DK0752847T3 (da) Ophthalmisk sammensætning med nedsat viskositet
SE9401109D0 (sv) Opthalmic composition II
US5945121A (en) Liposome eye drops
AU625099B2 (en) Aqueous antimicrobial ophthalmic solutions
KR960700081A (ko) 콘택트렌즈 용액 보존 시스템(preservative system for contact lens solutions)
WO1998005365A3 (fr) Compositions et procedes de desinfection de lentilles corneennes et produits conservateurs d'entretien desdites lentilles
DE60012068D1 (de) Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
WO2009006130A3 (fr) Solution ophtalmique à base d'hyaluronate exempte de sel
JPS6452727A (en) Antiallergic eye drop
FI963744A (fi) Alennetun viskositeetin omaava oftalminen koostumus
AU2001242398A1 (en) Contact lens treating method and composition